| Literature DB >> 19644922 |
Jean-François Mayol1, Corinne Loeuillet, Francis Hérodin, Didier Wion.
Abstract
The characterisation of normal stem cells and cancer stem cells uses the same paradigm. These cells are isolated by a fluorescence-activated cell sorting step and their stemness is assayed following implantation into animals. However, differences exist between these two kinds of stem cells. Therefore, the translation of the experimental procedures used for normal stem cell isolation into the research field of cancer stem cells is a potential source of artefacts. In addition, normal stem cell therapy has the objective of regenerating a tissue, while cancer stem cell-centred therapy seeks the destruction of the cancer tissue. Taking these differences into account is critical for anticipating problems that might arise in cancer stem cell-centred therapy and for upgrading the cancer stem cell paradigm accordingly.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19644922 PMCID: PMC5410217 DOI: 10.1002/bies.200900041
Source DB: PubMed Journal: Bioessays ISSN: 0265-9247 Impact factor: 4.345